Immunotherapy for virus infection.
Immunotherapy for virus infection.
复制标题
病毒感染的免疫治疗。
DOI:
10.1007/978-3-642-71726-0_9
复制
发表时间:
1987
影响因子:
--
通讯作者:
Oldstone,MB
中科院分区:
文献类型:
--
作者:
Oldstone,MB
Understanding of virus-induced immune response disease and the related immunopathology has its roots in the studies reported byRowe(1954). He showed that suppression of immune responses changed the ordinarily lethal, acute infection with lymphocytic choriomeningitis virus (LCMV) to a persistent infection in susceptible mice. The subsequent work of many investigators who used neonatal thymectomy, genetically athymic mice, irradiation, antilymphoid drugs, or antithymocyte sera, etc. (reviewed inBuchmeeeret al. 1980) extended the concept of immune response-mediated injury during viral infection. Thereafter, the role of lymphocytes in mediating virus-induced immunologic injury was delineated. First, experiments performed independently byLundstedt(1969) andOldstoneet al. (1969) showed that lymphocytes obtained 6–9 days after an acute LCMV infection or primary inoculation killed LCMV-infected targets in vitro. Next, such lymphocytes were found to be of thymic origin and to bear Thy 1.2 markers of their surfaces (Coleet al. 1973;MarkerandVolkert1973).Gildenet al. (1972a, b) showed that mice which survived an ordinarily lethal dose of LCMV owing to immunosuppression developed acute lymphocytic choriomeningitis (LCM) disease and died when reconstituted with syngeneic, immune T-lymphocytes.ZinkernagelandDoherty(1974 a) defined the need for two signals between the cytolytic T-lymphocyte and its infected target, namely, virus specificity and H-2 restriction, so that killing of LCMV-infected cells could proceed.